Company Analysis
Sign in

PROCEPT BioRobotics Corporation (PRCT)

Nasdaq: PRCT · Surgical & Medical Instruments & Apparatus · San Jose, CA · filing with the SEC since 2013
Full chart Alerts Compare
Grade6.2
◀ Past 7.1● Present 5.7▶ Future 6.0
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Report filedFeb 26, 2026Feb 27, 2025Feb 28, 2024Feb 28, 2023Mar 22, 2022·
Revenue308,054224,498136,19175,01434,4737,717
For lenders
Provision for credit losses·84000··
Cost of revenue111,82887,39965,14237,92918,6088,972
Gross profit196,226137,09971,04937,08515,865-1,255
Research and development71,27762,29848,44628,98118,99316,275
Selling, general and administrative228,808171,415131,77388,82851,03630,272
Total operating expenses300,085233,713180,219117,80970,02946,547
Operating income-103,859-96,614-109,170-80,724-54,164-47,802
Interest expense3,5864,1843,9955,1835,8105,261
Interest and investment income12,21910,8957,5512,49776184
Other income (expense), net-156-1,028r-96r-203-154-25
Income before income taxes-95,382-91,045-105,817···
Income tax expense190368r80r000
Net income-95,572-91,413-105,897-87,154-59,853-53,019
Earnings per share, basic-1.72-1.75-2.24-1.96-3.63-14.47
Earnings per share, diluted-1.72-1.75-2.24-1.96-3.63-14.47
Weighted average shares, basic55,54452,12547,25544,40016,4803,663
Weighted average shares, diluted55,54452,12547,25544,40016,4803,663
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Provision for credit losses set aside for loans that may not be repaidus-gaap:ProvisionForLoanLeaseAndOtherLosses
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton PRCT · research, not advice